Moreover, novel biomarkers like angiopoietin 2 (ANGPT2), osteopontin (OPN), and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) appear to be associated with both left ventricular (LV) and right ventricular (RV) dysfunction in SSc [79]. Here, ANGPT2 is linked to systemic sclerosis.